Clinical Trials Browser

Phase 4 × Uterine Cervical Neoplasms × Breast × Clear all

NCT03384511 2018-02-20

The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.

Phase 4 Completed

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT00613275 2016-06-15

Patient Navigation in the Safety Net:CONNECTeDD

Phase 4 Completed

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms